Bayer Pharmaceuticals

7 Stories

Man Awarded $2.25B in Latest Roundup Lawsuit

Bayer calls award 'unconstitutionally excessive'

(Newser) - Bayer has been ordered to pay a Pennsylvania man $2.25 billion in a verdict that "sends a clear message that this multi-national corporation needs top to bottom change," the man's lawyers say. A jury awarded the man the sum—which includes $2 billion in damages—after...

Man Who Blames Roundup for His Cancer Awarded $80M

Edwin Hardeman has non-Hodgkin's lymphoma

(Newser) - Bayer inherited thousands of lawsuits when it bought Monsanto —and after the latest lawsuit involving the latter company's Roundup weed killer, the German pharma giant may be experiencing buyer's remorse. A jury in San Francisco federal court Wednesday ordered Bayer to pay $80 million to a man...

Chemical Brothers: Monsanto Acquired by Bayer for $66B

Bayer AG is paying big bucks to acquire the seed and weedkiller company

(Newser) - After months of courtship, German drug and farm chemical maker Bayer AG has finally reached an agreement to buy US seed and weedkiller company Monsanto, in a deal valued at $66 billion, the AP reports. In a statement Wednesday, Bayer said it's paying Monsanto shareholders $128 per share in...

4 Things to Know About the $62B Bid for Monsanto

Bayer announces specifics of its bid

(Newser) - A German company, in a country that's definitely no fan of genetically modified crops, has offered to buy the world's biggest producer of the seeds they come from for $62 billion—in cash. Bayer on Monday said its offer of $122 a share is a 37% premium over...

FDA Slaps Birth Control Giant Over Deceptive Ads

Bayer ordered to air clarifying spots for Yaz

(Newser) - Bayer Pharmaceuticals has just launched a $20 million ad campaign for Yaz, the country's most widely used birth control pill. But the ads aren't promoting the drug; rather, they're clarifying earlier commercials that seemed to say Yaz prevented acne and mood swings. As the New York Times reports, the FDA ...

FDA Delay Cost 22,000 Lives: Doctor
FDA Delay
Cost 22,000 Lives: Doctor

FDA Delay Cost 22,000 Lives: Doctor

Agency took a year to pull lethal heart surgery drug Trasylol

(Newser) - A prominent researcher who revealed widespread fatalities associated with the heart surgery drug Trasylol says 22,000 people died because of the FDA's delay in blowing the whistle on the drug after his study was published. Drugmaker Bayer also failed to disclose negative results of its own study. In a...

Sales of Heart-Surgery Drug Halted
Sales of Heart-Surgery Drug Halted

Sales of Heart-Surgery Drug Halted

Anti-bleeding med yanked after study shows higher death risk

(Newser) - Bayer Pharmaceuticals will suspend the sale of Trasylol, a drug used to control bleeding during heart bypass surgery, after a clinical study found that the drug puts patients at increased risk of death, the Washington Post reports. The FDA said sales of the drug would be halted at least until...

7 Stories
Most Read on Newser